Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (34 quarters reported)
$166M in Q1 2014 → $2M now. Hover for any quarter.
As reported for the quarter ended December 31, 2023. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| C& Cbl & Assoc Pptys Inc | 100.0% | Unchanged | 82,081 | $2M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended December 31, 2023 · filed February 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Ebix Inc | Exited | −8,061 | −$79.6K | — |
| AE Amplify Energy Corp New | Exited | −953 | −$7.01K | — |
quarter ended September 30, 2023 · filed November 14, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| LH Lantheus Hldgs Inc | Exited | −200,777 | −$16.8M | — |
| C& Cbl & Assoc Pptys Inc | Added | +21,686 | +$455K | 95.2% |
| Ebix Inc | New | +8,061 | +$79.6K | 4.4% |
quarter ended June 30, 2023 · filed August 14, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| LH Lantheus Hldgs Inc | Added | +100,777 | +$8.46M | 92.6% |
| C& Cbl & Assoc Pptys Inc | Exited | −82,081 | −$2.1M | — |
| Novartis Ag | Exited | −22,000 | −$2.02M | — |
| UT United Therapeutics Corp Del | Exited | −9,000 | −$2.02M | — |
| IQ Invesco Qqq Tr | Exited | −4,800 | −$1.54M | — |
| C& Cbl & Assoc Pptys Inc | New | +60,395 | +$1.33M | 7.3% |
| NA Novo-nordisk A S | Exited | −7,000 | −$1.11M | — |
| SS SPDR S&P 500 ETF Tr | Exited | −2,500 | −$1.02M | — |
| FR First Rep Bk San Francisco C | Exited | −52,000 | −$727K | — |
| GC Global Cord Blood Corporatio | Exited | −279,495 | — | — |
quarter ended March 31, 2023 · filed May 15, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| LH Lantheus Hldgs Inc | Added | +82,923 | +$6.85M | 43.9% |
| Lifecore Biomedical Inc | Exited | −373,778 | −$2.42M | — |
| C& Cbl & Assoc Pptys Inc | New | +82,081 | +$2.1M | 11.2% |
| Novartis Ag | New | +22,000 | +$2.02M | 10.8% |
| UT United Therapeutics Corp Del | New | +9,000 | +$2.02M | 10.7% |
| C& Cbl & Assoc Pptys Inc | Exited | −78,316 | −$1.81M | — |
| IQ Invesco Qqq Tr | New | +4,800 | +$1.54M | 8.2% |
| NA Novo-nordisk A S | New | +7,000 | +$1.11M | 5.9% |
| SS SPDR S&P 500 ETF Tr | New | +2,500 | +$1.02M | 5.4% |
| CI Cryo-cell Intl Inc | Exited | −195,031 | −$825K | — |
Showing the 10 largest of 12 changes.
quarter ended December 31, 2022 · filed February 14, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| NT Nam Tai Ppty Inc | Exited | −6,918,372 | −$29.2M | — |
| Lifecore Biomedical Inc | Trimmed | −1,156,874 | −$7.5M | 32.4% |
| LH Lantheus Hldgs Inc | Trimmed | −119,173 | −$6.07M | 11.6% |
| C& Cbl & Assoc Pptys Inc | Trimmed | −54,000 | −$1.25M | 24.2% |
| Carvana Co | New | +150,000 | +$711K | 9.5% |
| CI Cryo-cell Intl Inc | Trimmed | −83,842 | −$355K | 11.0% |
| AE Amplify Energy Corp New | New | +953 | +$8.38K | 0.1% |
quarter ended September 30, 2022 · filed November 14, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| LH Lantheus Hldgs Inc | New | +136,250 | +$9.58M | 16.4% |
| L Landec Corp | Trimmed | −710,742 | −$6.32M | 23.3% |
| R Renren Inc | Exited | −146,525 | −$4.24M | — |
| HM Hemisphere Media Group Inc | Exited | −337,868 | −$2.58M | — |
| C& Cbl & Assoc Pptys Inc | Added | +50,506 | +$1.29M | 5.8% |
| NT Nam Tai Ppty Inc | Trimmed | −301,000 | −$1.27M | 50.1% |
| GC Global Cord Blood Corporatio | New | +279,495 | +$836K | 1.4% |
| CI Cryo-cell Intl Inc | Trimmed | −74,337 | −$453K | 2.9% |
quarter ended June 30, 2022 · filed August 15, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Inotiv Inc | Exited | −264,598 | −$25.2M | — |
| R Renren Inc | New | +146,525 | +$4.24M | 6.7% |
| HM Hemisphere Media Group Inc | New | +337,868 | +$2.58M | 4.1% |
| C& Cbl & Assoc Pptys Inc | Trimmed | −49,290 | −$1.16M | 3.0% |
| L Landec Corp | Added | +64,445 | +$643K | 35.1% |
| CI Cryo-cell Intl Inc | Trimmed | −3,897 | −$23K | 3.3% |
quarter ended March 31, 2022 · filed May 16, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Inotiv Inc | Trimmed | −1,010,781 | −$96.3M | 29.9% |
| Avid Bioservices Inc | Exited | −2,208,313 | −$64.4M | — |
| Xpel Inc | Exited | −103,860 | −$7.09M | — |
| C& Cbl & Assoc Pptys Inc | New | +131,100 | +$4.31M | 5.1% |
| NT Nam Tai Ppty Inc | Added | +546,010 | +$3.41M | 53.5% |
| CI Cryo-cell Intl Inc | Trimmed | −125,824 | −$960K | 3.2% |
| L Landec Corp | Added | +251,638 | +$801K | 8.2% |
| GC Global Cord Blood Corporatio | Exited | −1,000 | −$4K | — |
Loading...
